Navigation Links
Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments
Date:6/18/2013

New York, New York (PRWEB) June 18, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, reports that the results of Yale University’s independent review of Medtronic’s Infuse bone graft products are now available. Published this week in Annals of Internal Medicine, a medical journal, the two studies serve up two key findings: There is “little to no difference in effectiveness” when comparing Infuse and the traditional bone graft; and there is “substantial evidence” that the initial Medtronic Infuse research was biased, according to a June 18 report in the (Minneapolis) StarTribune.

Specifically, the early research underreported side effects and emphasized favorable results, noted a June 17 Reuters report.

As for the supposed “underreported side effects,” Infuse allegedly poses potential health risks for patients: a small, increased risk of cancer, according to one team, headed by scientists at Oregon Health and Science University, the New York Times reported on June 17. Infuse also may possibly be linked to retrograde ejaculation, a cause of male infertility that occurs when semen is redirected to the urinary bladder rather than ejaculated via the urethra, according to a June 17 report on the Milwaukee-Wisconsin Journal Sentinal’s website.

And while Medtronic’s product did fuse spinal vertebrae more quickly than a traditional bone graft, the speed factor “appeared to lack clinical relevance,” according to the other team, led by researchers from the University of York in England, as the New York Times article reported.

Dr. Harlan M. Krumholz, a Yale professor who oversaw the review, noted that while the two teams’ findings slightly varied, they still pointed in the same direction. “The general, overall picture is that they failed to find a big benefit” for Infuse, Dr. Krumholz told the New York Times. “And they found there might be some harms.”

“The research released this week on Medtronic’s Infuse is revealing,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “There may be no real advantage to using Infuse, except for the speed factor. At the same time there is a possibility that Infuse may cause cancer or, if you’re a male, sterility.”

Medtronic approached Yale University researchers after a June 2011 study published in The Spine Journal disclosed that Medtronic-paid researchers had failed to report serious potential complications from use of Infuse bone graft products in spinal surgery.

In addition, as noted in an Oct. 25, 2012, Bloomberg Businessweek report, the U.S. Senate Finance Committee found problems with most of the initial Medtronic-supported Infuse research used to promote the product. The article noted that doctors and researchers who authored at least 11 medical journal reports about Infuse were paid about $210 million in royalties and consulting fees. Senate investigators also charged that Medtronic deliberately manipulated studies to mitigate any adverse reactions to Infuse side effects, as well as to promote off-label use.

The U.S. Food and Drug Administration (FDA) approved Infuse in 2002 for use in fusing damaged vertebrae in the lower spine; Infuse was not approved for use on the upper, or cervical, spine, where it is now widely used, according to Bloomberg Businessweek report. In fact, the report added, the FDA released a July 1, 2008 notification warning that the Infuse Bone Graft had been associated with serious complications – including excessive swelling in the neck, compressed airways, difficulty breathing, problems swallowing and nerve damage – when used in cervical spinal fusions.

Parker Waichman LLP is currently offering free legal consultations to victims of Medtronic Infuse Bone Graft Injuries. If you or a loved one suffered a serious complication or injury after receiving Medtronic Infuse, please contact their office by visiting the firm's Medtronic Infuse injury page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/medtronic_infuse_yale/06/prweb10847089.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
2. Markle releases new resources for health information sharing implementation
3. ASCO releases studies from upcoming annual meeting
4. Boys Town Releases 5 Signs of Heat Stroke in Kids
5. MTSS-mba Membership Benefits Administration Software for Private and Taft-Hartley Employee Benefit Funds Releases New Pension Modules
6. Muscular Development Store Releases the Optimum Performance Workout for High Intensity Training
7. Premier global health journal, The Lancet, releases series on universal health coverage
8. Institute for Population Health Improvement releases buyers guide for health information exchange
9. CSHL Press releases new book on the biology of drug addiction
10. Nathan Wells Releases Audiobook Detailing Battle with Undiagnosed Medical Condition
11. Probiotic Action Releases a Statement in Regards to a Recent Miami Herald Article on Minimizing Scars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... Mich. , Sept. 18, 2017  PMD Healthcare ... Specialty Pharmacy of Kalamazoo, Mich. , ... hub service that expedites and streamlines patient and provider ... PD 2.0, and wellness management services.  ... device used to measure lung function for a variety ...
Breaking Medicine Technology: